Seed Biotech, Inc.

03/20/2025

https://www.seedbiotech.com/blog/2025/3/20/seed-biotech-inc-at-aaos-2025-connecting-learning-and-innovating

Seed Biotech, Inc., the manufacturer of Aril would like to thank everyone who stopped by our booth at this year’s AAOS 2025! We are extremely grateful for the engaging conversations, thoughtful questions, and exchange of ideas that made this event such a success. It was an incredible opportunity t...

02/19/2025

https://www.seedbiotech.com/blog/2025/2/18/notice-temporary-closure-and-order-processing-delays-1

Dear Valued Customers, Due to forecasted inclement weather, Seed Biotech, Inc. will be closed on Wednesday, February 19, 2025, prioritizing the safety of our employees. Consequently, orders scheduled for same-day processing will experience delays.  Revised Shipping Schedule:  &a

12/30/2024

https://www.seedbiotech.com/blog/2024/12/30/thank-you-for-a-successful-2024

As we wrap up the year, Seed Biotech, Inc. extends our sincere appreciation to our physicians and strategic partners for their support throughout 2024. Your dedication and collaboration have been instrumental in advancing our mission and driving meaningful progress. We look forward to building on t

11/14/2024

https://www.seedbiotech.com/blog/2024/10/23/thanks-to-chicago-and-the-american-academy-of-ophthalmology-for-hosting-this-years-event-bjlz5

Seed Biotech, Inc would just like to say thank you to all the attendees who took the time to stop by our booth at this years event to learn more about our product Aril.

08/07/2024

https://www.seedbiotech.com/blog/2024/8/7/seed-biotech-inc-announces-its-voluntary-decision-to-discontinue-production-marketing-and-sales-of-its-petil-product-line

Seed Biotech, Inc. continually assesses the regulatory landscape and applicable guidance documents for its products.  Based on recent assessments and discussions with the FDA, Seed Biotech, Inc. is announcing its decision to voluntarily discontinue produc

12/28/2023

Seed Biotech® was created for the purpose of pioneering advanced research, development, production, distribution, and effective use of intelligently designed biological material based products. Process and product designs encompass defined competitive advantage features through the use and integration of numerous core system technologies. Contact us now for more info on our allograft products!

12/01/2023

What makes us different?

Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness, there were numerous considerations incorporated into the design of our product lines. From the packaging it is stored in, to the shape it is configured in, it all relates to optimizing its suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, our products were developed with design requirements for safety, and products provided are verified to satisfy these requirements.

11/15/2023

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting donors. Post-decellularization and stabilization, Petil™ is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Petil™ is an acellular particulate human placental connective tissue matrix intended to replace or supplement damaged or inadequate integumental tissue. Petil™ is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

10/17/2023

Aril® is a room temperature stable allograft derived from human placental tissue collected from consenting donors. Post-decellularization & stabilization, Aril® is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Aril® is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

For more info contact us at [email protected]

08/24/2023

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting donors. Post-decellularization and stabilization, Petil™ is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Petil™ is an acellular particulate human placental connective tissue matrix intended to replace or supplement damaged or inadequate integumental tissue. Petil™ is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

08/08/2023

Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness, there were numerous considerations incorporated into the design of our product lines. From the packaging it is stored in, to the shape it is configured in, it all relates to optimizing its suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, our products were developed with design requirements for safety, and products provided are verified to satisfy these requirements.

Link is in our bio for more information.

07/25/2023

Aril® is configured as a precision cut single layer of amnion shaped as an ellipse or disc. The configuration was selected and designed to maximize clinical usable surface area and limit necessary pre-operative manipulation of the graft. Seed Biotech, Inc. has shown a greater than 95% reduction in DNA using their proprietary decellularization process. As a single layer of amnion, it is not necessary to emboss Aril® as there is no side-specific orientation to the graft.